• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

7
2
2
2
1

COUNTRY

1
1
1
1

CATEGORIES

  • 11
  • 1
  • 1
  • 1

PRICE

0
0
3
12

PUBLISHED

0
0
4
12

PRODUCT TYPE

12

Search "Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011 " returned 12 results.

PRODUCT TITLE
Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report - Product Thumbnail Image

Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report

TechNavio's analysts have conducted a survey on Impact of Patent Expiration on Key Drugs Categories for 2012-2016. The survey assessed the Impact of Patent Expiration on several key drugs categories...

November 2012
FROM
Pharmaceuticals - Global Outlook Pharmaceuticals - Global Outlook - Product Thumbnail Image

Pharmaceuticals - Global Outlook

The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings Punctuated with 46 statistically rich tables, the...

January 2012
FROM
Global Biopharma Outlook 2011: Major US and EU Global Biopharma Outlook 2011: Major US and EU - Product Thumbnail Image

Global Biopharma Outlook 2011: Major US and EU

The year 2011 and 2012 will be a bonanza for generic companies, as large innovator companies will lose patent exclusivity on prescription drugs worth over $70b in sales It is imperative to understand...

February 2011
FROM

Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management

GBI Research, the leading business intelligence provider, has released its latest research, “Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough...

May 2012
FROM
Global Biopharma Outlook 2011 Global Biopharma Outlook 2011 - Product Thumbnail Image

Global Biopharma Outlook 2011

Global Pharmaceutical and Biotechnology Outlook 2011 is an extensive, yet conclusive research work that encompasses a comprehensive, historical and forward looking analysis of 80 small and large cap...

January 2011
FROM
Hormone Replacement Therapy (HRT) - Global Strategic Business Report Hormone Replacement Therapy (HRT) - Global Strategic Business Report - Product Thumbnail Image

Hormone Replacement Therapy (HRT) - Global Strategic Business Report

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America,...

January 2014
FROM
China Pharmaceutical Market Overview China Pharmaceutical Market Overview - Product Thumbnail Image

China Pharmaceutical Market Overview

The Chinese hospital prescription pharma market generated sales of $22.9 billion in 2009, with an annual growth rate of 26.5% between 2008 and 2009. Key growth drivers include China’s support of foreign...

November 2010
FROM

Healthcare, Regulatory and Reimbursement Landscape - Sweden

Healthcare, Regulatory and Reimbursement Landscape - Sweden Summary GlobalData, the industry analysis specialist, has released its new report “Healthcare, Regulatory and Reimbursement Landscape -...

March 2013
FROM

Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019

Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Posttraumatic...

June 2012
FROM
Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma - Product Thumbnail Image Special Offer Sale Banner

Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma

2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations The authors find these...

January 2014
FROM

OpportunityAnalyzer: Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Summary The acute ischemic stroke (AIS) market is poised for major changes during the forecast window out to...

December 2013
FROM
Market Access Collection Market Access Collection - Product Thumbnail Image

Market Access Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Loading Indicator